Market Tracker

04/29 5:16pm ET

Mannkind Corp (NASDAQ:MNKD)

1.35
Delayed Data
As of 4:00pm ET
 -0.09 / -6.25%
Today’s Change
0.64
Today|||52-Week Range
7.32
-6.90%
Year-to-Date

Today’s Trading

Previous close1.44
Today’s open1.38
Day’s range1.33 - 1.41
Volume2,914,193
Average volume (3 months)6,993,973
Market cap$617.6M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+77.75%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PDLIPDL BioPharma Inc+0.01+0.27%
EGRXEagle Pharmaceutical...-1.39-3.54%
SRPTSarepta Therapeutics...+0.39+2.83%
EPZMEpizyme Inc-0.64-5.79%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 9, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts